
Experimental Propulsion Tech Could Reach Mysterious Planet Beyond Pluto in 10 Years
A team of researchers from Italy suggests mission concepts that could reach Sedna in seven to 10 years using cutting-edge technology. In a paper available on the pre-print website arXiv, they illustrate two experimental propulsion concepts that involve a nuclear fusion rocket engine and a new take on solar sailing technology. The propulsion technologies could cut down travel time to Sedna by more than 50% compared to traditional methods of space travel, allowing scientists a unique opportunity to gather clues about the early formation of the solar system and probe the theoretical Oort Cloud.
When it was discovered, Sedna was around 8 billion miles (13 billion kilometers) from the Sun. (Pluto, the most famous dwarf planet, has an average distance of 3.7 billion miles from the Sun.) Sedna is known as a Trans-Neptunian object, a group of objects that orbit the Sun farther out than Neptune. It has an extremely eccentric orbit: at its farthest distance, Sedna is 84 billion miles away from the Sun, or 900 times the distance between Earth and our star. During its closest approach, Sedna will be around 7 billion miles away from the Sun, nearly three times farther than Neptune. That's still far, but it's close enough for a spacecraft to reach the celestial object before it fades back into ultra-distant darkness.
Spacecraft have traveled farther distances before. Voyager 1 and 2 started their interstellar journey in 1977 and have traveled 15 billion miles and 12.7 billion miles thus far. It took Voyager 2 around 12 years to reach Neptune. Based on current technology, scientists estimate it would take around 20-30 years to reach Sedna during its closest approach, while using Venus, Earth, Jupiter, and Neptune as gravity assists. That would mean the launch window to reach Sedna is fast approaching, with no clear plans yet in place.
Instead, the researchers behind the new study suggest alternative methods to get us there faster. The first is the Direct Fusion Drive (DFD) rocket engine, which is currently under development at Princeton University's Plasma Physics Laboratory. The fusion-powered rocket engine would produce both thrust and electrical power from a controlled nuclear fusion reaction, providing more power than chemical rockets.
'The DFD presents a promising alternative to conventional propulsion, offering high thrust-to-weight ratio and continuous acceleration,' the researchers write in the paper. 'However, its feasibility remains subject to key engineering challenges, including plasma stability, heat dissipation, and operational longevity under deep-space radiation.' They add that, while advances are being made for fusion-based propulsion, it's still unclear whether it can support long-duration missions and provide power for onboard instruments.
The second concept builds on existing solar sail technology, which is still experimental in its own right. Solar sails are powered by photons from the Sun, harnessing energy produced by light and using it to propel spacecraft forward. The researchers suggest coating the solar sails with material that, when heated, releases molecules or atoms and provides propulsion in a process known as thermal desorption.
The solar sail, assisted by Jupiter's gravity, could reach Sedna in seven years due to its ability to continuously accelerate without the need to carry heavy fuel, according to the paper. The idea does come with its own set of challenges. 'While solar sailing has been extensively studied for deep-space applications, its feasibility for a Sedna mission requires assessment in terms of long-duration structural integrity, propulsion efficiency, and power availability for science operations,' the paper reads.
Despite a slight time advantage, the solar sail mission would only allow for a flyby of Sedna, while the DFD engine could insert a spacecraft into the dwarf planet's orbit for a longer mission. Either mission would provide us with the first direct observations of the previously unexplored region and help scientists better understand the larger boundary that houses the solar system.
Hashtags

Try Our AI Features
Explore what Daily8 AI can do for you:
Comments
No comments yet...
Related Articles
Yahoo
3 hours ago
- Yahoo
Researchers make crucial discovery on journey toward limitless energy machine: 'A much more reliable method'
Scientists at École Polytechnique Fédérale de Lausanne have developed a solution that prevents fusion reactors from overheating, reported. The breakthrough centers on a clever design called the X-point target radiator. This innovation adds a second magnetic control point to tokamak fusion reactors, creating a safety valve that sheds dangerous excess heat before it can damage the reactor walls. Fusion reactors face a massive heat management problem. These doughnut-shaped devices, called tokamaks, use powerful magnetic fields to contain plasma heated to over 100 million degrees Celsius. When this superhot plasma touches the reactor walls, it can cause severe damage that shortens the reactor's lifespan and hurts performance. The Swiss research team discovered that adding a secondary X-point along the reactor's heat exhaust channel creates localized radiation that pulls heat away from sensitive areas. Think of it like adding a second drain to prevent your bathtub from overflowing. "Reducing divertor heat loads is a key challenge for future fusion power plants," Kenneth Lee, first author of the paper, told The EPFL team used its TCV tokamak's unique magnetic shaping abilities to test this concept. Experiments showed the X-point target radiator stays stable across a range of operating conditions, making it much more reliable than previous heat management approaches. "We found that the X-point target radiator is highly stable and can be sustained over a wide range of operational conditions, potentially offering a much more reliable method for handling power exhaust in a fusion power plant," Lee said. Fusion energy could change how we power our world. Unlike coal and gas, fusion creates massive amounts of electricity without producing harmful gases or long-lived radioactive waste. A single fusion plant could power entire cities on fuel extracted from seawater. The X-point target radiator makes fusion power plants more practical by solving the overheating problem that has plagued reactor designs. This means fusion plants could run longer and more efficiently, reducing electricity costs for everyone. Commonwealth Fusion Systems and the Massachusetts Institute of Technology plan to include the X-point target design in their upcoming SPARC reactor, which looks to demonstrate commercial fusion power. Should the government be paying us to upgrade our homes? Definitely Depends on how much it costs Depends on what it's for No way Click your choice to see results and speak your mind. Diversifying our energy sources with fusion power would dramatically reduce air pollution from coal and gas plants. Cleaner air means fewer respiratory problems, heart disease cases, and premature deaths in communities near power plants. Fusion power could slash electricity bills once the technology scales up. The fuel comes from abundant hydrogen isotopes found in seawater, making long-term operating costs extremely low. Cities and companies investing in fusion power could reap major savings compared to volatile coal and gas prices. The stable costs of fusion electricity would help businesses plan budgets and keep energy affordable for residents. The SPARC reactor incorporating this heat management technology is scheduled for testing in the coming years. If successful, commercial fusion plants using the X-point target radiator could begin operating in the 2030s. The researchers will continue refining their approach with high-power experiments and simulations. Join our free newsletter for weekly updates on the latest innovations improving our lives and shaping our future, and don't miss this cool list of easy ways to help yourself while helping the planet.


WIRED
3 hours ago
- WIRED
How to Travel to the Most Remote Office on Earth
Jul 2, 2025 9:00 AM Commuting to Concordia research station in Antarctica takes days—it's more remote than the International Space Station. Here's how to get there. Photograph: ESA/IPEV/PNRA - B. Healey In November 2023, Jessica Studer, a 33-year-old research medical doctor and professional pianist from Bremgarten, Switzerland, prepared for her trip to Antarctica's Concordia research station. Most work trips require a flight and a few nights in a hotel; hers would involve several days of travel and a year at the most remote outpost in the world. Very few people have experience preparing for such an extreme journey. Concordia sits at 10,600 feet above sea level, with winter temperatures plummeting to minus 112 degrees Fahrenheit. It's accessible only by aircraft during the summer months, from November to February, and the station is more isolated than the International Space Station, 240 miles above Earth's surface. Studer spent a full year at the station conducting biomedical research for the European Space Agency. Concordia, operated by the French Polar Institute and Italy's National Antarctic Research Program, serves in part as a simulation of a space station. During her time there, Struder studied the effects of isolation and confinement on herself and her crewmates to better understand what could happen to astronauts on long deep-space missions. WIRED spoke with Studer about how she got to her very remote office. Concordia research station, which consists of two towers connected by a tunnel, can serve as a simulation of a space station. Photograph: ESA/IPEV/PNRA - B. Healey The journey started with a train to Paris, arriving at Gare de Lyon. I decided to take an Uber to the airport. That was super interesting, because Uber drivers always like to chat, and when you're sitting in the car and say 'I'm going to Antarctica for a year' they just look at you, with the three backpacks, like, You're not serious, right? At the Paris airport, I met some of the French crew for the first time. We flew to Christchurch, New Zealand, (with a layover in Singapore) and that's when I really connected with the other two women going to Antarctica. We sat next to each other, discussing things like, 'How is it going to be?' 'What did you pack?' 'Did you take more clothes than they're giving us?' 'Do you have special equipment?' It was a chat about everyone's strategies, what we did, what we had, if we took medical supplies from the lab. In the morning, we met in front of our hotel in Christchurch and took some small buses. The crew helped me carry my bags because I was still downloading data from my cloud to ensure I'd have it in Antarctica. So there I was, ready to go to the airport, still downloading. I was super stressed. At the airport, every bag is checked. They make sure you don't have more kilograms than allowed, as that's an issue for the plane. They also ensure you don't have anything not allowed in Antarctica, like seeds, food, or plants. Basically, they want to make sure the continent stays as it is. The plane is a Hercules C-130, super impressive. You arrive on this little bus, and you see this monstrous plane, and you enter through the back. Then you sit next to each other in these longitudinal seats. And then it's departure for a seven-hour trip without toilets, with a little snack, a lot of sound around you—just sitting until you see, for the first time, a bit of Antarctica. Concordia is more isolated than the International Space Station, 240 miles above Earth's surface. Photograph: ESA/IPEV/PNRA - A. Kumar You see these wonderful ice shelves from the little windows you have there. The first thing you see when you step out is just ice everywhere. You're really new to this environment, and sometimes it feels a little bit like being on another planet. There's an Italian station there, and we were supposed to stay for a day. But what we learned very fast is that, in French, we say, en Antarctique pas de pronostique , meaning, 'no forecast in Antarctica,' because the weather is super unpredictable. So, instead of staying one night, we stayed almost a week. This station is just a logistical one; it's not meant to host people, and everyone who stays there blocks others from coming in. It's a real logistical challenge for the people working there, so they want us to leave as fast as possible. But the weather is so unpredictable that you can't just take a plane and go inland. You need to wait until the weather is almost stable, and the pilot says, 'I'm ready to fly,' because he has the final word. I still had my data problem from before, and I was trying to connect to the internet. There, it was like the internet of the '90s—you know, beep beep beep . I tried to log in, and finally, after maybe two or three hours, on one computer, I got to the stage where it said, 'OK, I'm going to log in to your account so you can download your stuff. Please give me your phone number. I'm going to send you an SMS to log in.' That was the double verification, and it wasn't working because, obviously, there's no phone service. So I couldn't access my data because of this double verification. Finally, we took a plane. This one is smaller, a Basler BT-67 plane, which comes from Canada to fly within Antarctica and then goes back to Canada at the end of the season. This plane ride took four hours. It's a non-pressurized plane. You make sure to put all your clothes on, to be ready to go out in Concordia, because it's about minus 30 Celsius. We were super afraid. The first thing after landing in Concordia was this feeling of dizziness, vertigo. What I didn't know when I arrived there is that you're at 3,200 meters above sea level, so you feel the altitude a little bit. After four hours in this small plane, where you just see flatness of white, and nothing else, you come down to Concordia. From a distance, you see the station. That station seems so small because there's literally nothing around it—no mountains, nothing. And you have this little boulot dans l'estomac , as we say in French, like butterflies, because, you know, 'Wow, that's going to be my home for one year.' We came down to Concordia station, and the crew that had just spent a year and was now leaving the station, was awaiting us and welcomed us very warmly. They got us inside the station because we were sometimes afraid of high-altitude sickness. They want to make sure no one is carrying anything heavy, that we're not doing physical activity. They told us, 'Just stay calm for the next few days.' Concordia is accessible only by aircraft during the summer months, from November to February. In winter, temperatures plummet to minus 112 degrees Fahrenheit. Photograph: ESA/IPEV/PNRA - A. Kumar The station is made of two towers, with 18 faces for each tower. It's basically white, with a little bit of orange, and that's it. You enter through a tunnel between the two towers. You take off your boots and leave all your stuff there. It's quite small. Then you can go to the left, which is the 'calm tower.' Inside, you have the dormitories, the laboratories, and the hospital. It has three floors. The middle floor is dormitories, and the upper floor is laboratories. It's called the 'calm tower' to keep it calm. Then we go to the other tower, on the right side from the entrance. It has the technical stuff. On the second floor, there's the video room for movies and the sports room. On the top, you have the living room, the eating area, and the kitchen. In five minutes, you've done the tour of your new home. It's super impressive because you think, 'Someone had to build this in the middle of nowhere. Someone had to take the first steps.' And this is just incredible. So many people go to Antarctica with nothing. We arrive here, and we have the luxury of having this building to protect us from this environment. It's so out of this world to be there. We've seen a lot of pictures of Antarctica, and we've probably read a lot of books, but you've never been in the center of Antarctica, which is quite different. There's no life—no birds, no trees—there's literally nothing, nothing but ice and wind.
Yahoo
3 hours ago
- Yahoo
Pneumagen Announces Peer-Reviewed Publication of Positive Phase II Study Data Highlighting the Potential of Neumifil, a Novel Broad-Spectrum Antiviral
Pneumagen's intranasal broad-spectrum antiviral therapy reduced infection, improved symptoms and severity and reduced viral load in a Phase II influenza study in data published in the high-impact, peer-reviewed Infectious Diseases and Therapy journal. St Andrews, UK – 2 July 2025 - Pneumagen, a clinical stage biotech company developing Neumifil (HEX17), a broad-spectrum antiviral, intranasal drug for the prophylaxis and treatment of viral respiratory tract infections (RTIs), announces the publication of its Phase II Proof of Concept, Controlled Human Infection Model (CHIM) study investigating the efficacy and safety of Neumifil in the peer-reviewed journal Infectious Diseases and Therapy. These clinical data are published in a paper entitled, 'A Phase II, randomised, double-blind, placebo-controlled study to evaluate the efficacy of HEX17, a novel broad-spectrum antiviral drug, in a controlled human infection model of influenza challenge,' and confirm the potential of Neumifil as a first in class protein-based antiviral treatment for respiratory viral infections. The publication is available on the Publications page of our website. The published data highlight that Neumifil reduces the incidence of symptomatic influenza infection in a clinically and statistically significant way compared to placebo and has the potential to provide at risk patients with protection against infection by the influenza virus. Neumifil was well tolerated with no new emergent adverse events or safety signals from the study. The Phase II CHIM study ( Identifier NCT05507567) was a single centre, randomised, double-blind, placebo-controlled trial in 104 healthy adults evaluating two dose regimens of Neumifil, administered as an intranasal spray to participants who were subsequently infected with influenza virus. The primary outcomes were the incidence of symptomatic influenza infection and the severity of influenza symptoms in the pooled Neumifil arm versus placebo. Based on the promising preclinical and clinical data generated to date, Pneumagen is planning to advance Neumifil into further clinical studies. These will include the evaluation of Neumifil's ability to reduce the incidence of viral induced exacerbations in patients with underlying risk factors. Douglas Thomson, Chief Executive Officer at Pneumagen said: 'We are proud to have the results of our Phase II study of Neumifil published in a high-impact, peer-reviewed journal. This publication highlights the potential of our novel intranasal broad-spectrum antiviral therapy to dramatically improve outcomes for patients with virus-induced exacerbations and reduce the burden on healthcare systems worldwide.' Dr Geoff Kitson, Chief Medical Officer and lead author of the study, commented "There remains a significant unmet need in preventing viral-induced exacerbations in patients with underlying pulmonary diseases. In our study, we observed meaningful reductions in symptom severity and viral load, offering hope for a new, effective intervention for at-risk populations." END About Pneumagen Pneumagen is a clinical-stage biotech company developing Neumifil, its lead product, a broad-spectrum antiviral, intranasal drug for the prophylaxis and treatment of viral respiratory tract infections (RTIs). Neumifil is a novel, engineered, multivalent, Carbohydrate Binding Module (mCBM). It acts by directly binding and preventing the entry into the host of the viral pathogens. Neumifil was generated using Pneumagen's proprietary GlycoTarge™ technology. Pneumagen was established in 2016 as a spin-out from the University of St Andrews in Scotland giving Pneumagen access to world-class scientific expertise and capabilities in viral infections specifically related to glycobiology. For further information, please contact: Pneumagen Douglas Thomson, CEO Email: info@ MEDiSTRAVA Consulting (Financial PR) Sandi Greenwood, Frazer Hall Email: Pneumagen@ in retrieving data Sign in to access your portfolio Error in retrieving data Error in retrieving data Error in retrieving data Error in retrieving data